Article
Enhanced clinical-scale manufacturing of TCR transduced T-cells using closed culture system modules.
Journal of translational medicine - 24 Jan 2018
Jin Jianjian, Gkitsas Nikolaos, Fellowes Vicki S, Ren Jiaqiang, Feldman Steven A, Hinrichs Christian S, Stroncek David F, Highfill Steven L
Abstract excerpt
BACKGROUND: Genetic engineering of T-cells to express specific T cell receptors (TCR) has emerged as a novel strategy to treat various malignancies. More widespread utilization of these types of therapies has been somewhat constrained by the lack of closed culture processes capable of expanding sufficient numbers of T-cells for clinical application. Here, we evaluate a process for robust clinical grade...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
